Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "C"

11203 News Found

QMS Medical targets Rs. 500 crore revenue by FY29
Healthcare | June 23, 2026

QMS Medical targets Rs. 500 crore revenue by FY29

The company reported consolidated revenue of Rs. 172.9 crore and EBITDA of Rs 25.9 crore in FY26


India achieves landmark milestone of 5 lakh organ donation pledges
Policy | June 23, 2026

India achieves landmark milestone of 5 lakh organ donation pledges

As per union government, growing public participation reflects rising awareness and collective commitment towards advancing organ and tissue donation


KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute
Hospitals | June 23, 2026

KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute

Advanced comprehensive oncology centre was inaugurated by the legendary former Indian cricketer VVS Laxman


BioMed X and Biogen launch global neuroimmunology research challenge
R&D | June 23, 2026

BioMed X and Biogen launch global neuroimmunology research challenge

Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets


71% of Indians targeted by health scams amid rise of AI-generated misinformation: McAfee study
Healthcare | June 23, 2026

71% of Indians targeted by health scams amid rise of AI-generated misinformation: McAfee study

Social media emerges as the primary channel for health-related scams, while influencer endorsements and AI-generated content amplify risks for consumers


Pfizer lung cancer drug misses key survival goal in Phase 3 trial
Clinical Trials | June 23, 2026

Pfizer lung cancer drug misses key survival goal in Phase 3 trial

The company said the safety profile remained consistent with earlier studies and was considered manageable


Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study
Healthcare | June 23, 2026

Girls with ADHD from deprived backgrounds face sharply higher risk of long-term health conditions: Study

The research underscores growing concern that the intersection of neurodevelopmental conditions and social disadvantage can significantly compound health risks across the life course


AbbVie to acquire Apogee in $10.9 billion immunology power play
Biopharma | June 23, 2026

AbbVie to acquire Apogee in $10.9 billion immunology power play

Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards


Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego
Biotech | June 23, 2026

Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego

The company plans an aggressive partnering push, with 62 pre-scheduled meetings over four days, focused on out-licensing, co-development, and strategic collaborations with global pharmaceutical and biotech players


Pfizer CFO Dave Denton to exit
People | June 23, 2026

Pfizer CFO Dave Denton to exit

Pharma powerhouse names Cecile Guegan interim finance chief